Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 31

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 31
---
 Sciences, Inc.
     
    10-Q
     
    001-14895
     
    10.1
     
    5/4/17

     10.13†
     
    Employment Agreement, dated as of June 26, 2017, between Sarepta Therapeutics, Inc. and Douglas S. Ingram
     
    8-K
     
    001-14895
     
    10.1
     
    6/28/17

     10.14†
     
    Change in Control and Severance Agreement by and between Douglas S. Ingram and Sarepta Therapeutics, Inc., effective June 26, 2017
     
    8-K
     
    001-14895
     
    10.2
     
    6/28/17

     10.15†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan
     
    8-K
     
    001-14895
     
    10.3
     
    6/28/17

     10.16†
     
    Restricted Stock Agreement under the 2014 Employment Commencement Incentive Plan 
     
    8-K
     
    001-14895
     
    10.4
     
    6/28/17

     10.17†
     
    Performance Stock Option Award Agreement under the 2014 Employment Commencement Incentive Plan
     
    8-K
     
    001-14895
     
    10.5
     
    6/28/17

     10.18*
     
    Settlement Agreement between Sarepta Therapeutics, Inc., Sarepta International C.V. and The University of Western Australia on the one hand, and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMarin Technologies BV on the other hand dated July 17, 2017
     
    10-Q
     
    001-14895
     
    10.7
     
    8/3/17

-87-

     10.19*
     
    License Agreement between Sarepta Therapeutics, Inc.